Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2023 08:00 ET | Source: Robbins LLP

Eagle Pharmaceuticals Shareholders Still Have Time to Participate in the EGRX Class Action; Contact Robbins LLP Today

Eagle Pharmaceuticals, Inc. (EGRX) Misled Investors and Overstated its Revenue